BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Curocell And ProBio Achieve Korean Milestone With Approval Of Next Generation CAR T Therapy Anbal cel

Next-generation anti-CD19 CAR-T, Anbal-cel (CRC01), approval highlights Korean innovation Given the accelerating global momentum in CAR-T and gene th...

May 13, 2026 | News

Benchling Launches Antibody R&D Platform To Accelerate Biologics Discovery And Development

Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure a...

May 13, 2026 | News

Hengrui Pharma And Bristol Myers Squibb Forge $15.2 Billion Strategic Alliance Across Oncology And Immunology

Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreement...

May 13, 2026 | News

Medit Expands Into Orthodontics With Acquisition Of Progressive Orthodontics

Global digital dentistry leader expands into orthodontics by combining proprietary technology with one of the world's leading clinical education platforms ...

May 12, 2026 | News

ACROBiosystems Simplifies Global HEK293 Licensing To Accelerate Biopharma R&D Compliance

ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrat...

May 11, 2026 | News

Alebund Completes Global Phase III Enrollment For AP301 In Hyperphosphatemia Trial

Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies...

May 07, 2026 | News

Cellenkos Advances CK0802 Into Phase 1b 2a Trial Following FDA Clearance For Steroid Refractory GVHD

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with s...

May 06, 2026 | News

VectorBuilder Secures European Patent For MiniVec Plasmid System Advancing Genetic Medicine Development

Small by design, built for the demands of modern genetic medicine across gene therapy, cell therapy, and vaccines VectorBuilder, a global leader in ...

May 06, 2026 | News

Thermo Fisher Introduces Gibco CTS DynaXS Single Use Bioreactor For Scalable Cell Therapy Manufacturing

New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical productio...

May 05, 2026 | News

Cardioline Acquires Cardios To Expand Global Telecardiology And Diagnostic Capabilities

Strategic combination unites Cardioline’s global reach and proven cardiac technology with Cardios’s decades of clinical expertise in Holter m...

May 05, 2026 | News

CS Analytical Expands Clifton Facility To Double Laboratory Capacity

This facility expansion underscores the CS Analytical commitment to meeting the market demands of our clients as they work to...

May 05, 2026 | News

Olympus Corporation Partners With EndoRobotics To Advance Global Access To Robot Assisted Endoscopic Care

Partnership Aimed at Expanding Patient Access to Advanced EndoTherapeutic Procedures Olympus Corporation (Olympus), a global MedTech company co...

May 05, 2026 | News

Sonire Therapeutics Initiates SUNRISE II Trial To Advance Non Invasive HIFU Therapy For Pancreatic Cancer In The United States

SUNRISE-II feasibility trial marks the company's entry into U.S. clinical development, advancingminimally invasive, anesthesia-free treatment approach Son...

May 04, 2026 | News

Olympus And Canon Medical Expand Advanced Endoscopic Ultrasound Capabilities With Aplio i800 EUS Launch

Olympus Corporation and Canon Medical Systems USA, Inc. announced the U.S. launch of the Aplio i800 EUS premium ultrasound system. Manufactured by Canon In...

May 04, 2026 | News

Stay Connected